Haiping Hao

Title: Haiping Hao: Innovator in Medical Chemistry

Introduction

Haiping Hao is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of medical chemistry, particularly in the development of innovative drug compositions. With a total of two patents to his name, Hao's work focuses on addressing critical challenges in medical treatments.

Latest Patents

Hao's latest patents include a composition containing a SUMO inhibitor and its application. This composition is significant in the technical field of medicine, as it includes an FXR agonist and a SUMO inhibitor. The invention demonstrates that the FXR agonist alone does not inhibit the activation of hepatic stellate cells. However, when compounded with the SUMO inhibitor, it effectively inhibits the activation of these cells, which is crucial for individuals suffering from hepatic fibrosis.

Another notable patent is for a heterocyclic urea compound, specifically an indoleamine-2,3-dioxygenase inhibitor. This invention addresses the limitations of existing immunological therapy drugs, which often have weak curative effects and significant toxic side effects. The patent also outlines a preparation method for this inhibitor and its application in developing drugs for treating or preventing tumors.

Career Highlights

Haiping Hao has worked with esteemed institutions such as China Pharmaceutical University and Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Hao has collaborated with notable colleagues, including Hong Wang and Jiyu Zhou. These partnerships have likely enhanced his research capabilities and innovation potential.

Conclusion

Haiping Hao's contributions to medical chemistry through his patents reflect his commitment to advancing healthcare solutions. His innovative approaches to drug development are paving the way for more effective treatments in the medical field.